These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11298922

  • 1. Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.
    Guerrini R, Calo' G, Bigoni R, Rizzi D, Regoli D, Salvadori S.
    J Pept Res; 2001 Mar; 57(3):215-22. PubMed ID: 11298922
    [Abstract] [Full Text] [Related]

  • 2. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D.
    J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of nociceptin receptor: an in vitro study.
    Calò G, Rizzi A, Bodin M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D.
    Can J Physiol Pharmacol; 1997 Jun 27; 75(6):713-8. PubMed ID: 9276153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R.
    Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 15; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 7. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y, Caló G, Guerrini R, Smith G, Lambert DG.
    Neurosci Lett; 2000 Jan 07; 278(1-2):109-12. PubMed ID: 10643813
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
    Guerrini R, Caló G, Bigoni R, Rizzi D, Rizzi A, Zucchini M, Varani K, Hashiba E, Lambert DG, Toth G, Borea PA, Salvadori S, Regoli D.
    J Med Chem; 2001 Nov 08; 44(23):3956-64. PubMed ID: 11689082
    [Abstract] [Full Text] [Related]

  • 9. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
    Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R, Regoli D, Calo G.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May 08; 363(5):551-5. PubMed ID: 11383716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 08; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
    Salvadori S, Guerrini R, Calo G, Regoli D.
    Farmaco; 1999 May 08; 54(11-12):810-25. PubMed ID: 10668183
    [Abstract] [Full Text] [Related]

  • 15. The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia.
    Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo G.
    Neuroreport; 2000 Aug 03; 11(11):2369-72. PubMed ID: 10943687
    [Abstract] [Full Text] [Related]

  • 16. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR, Glen T, Davies MR, Paterson SJ, Corbett AD.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):217-23. PubMed ID: 10607879
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 19. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug 10; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT, Lambert DG.
    Br J Pharmacol; 1999 May 10; 127(1):123-30. PubMed ID: 10369464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.